The study tested whether PF’3944 could maintain efficacy when switching from weekly to monthly injections and remain safe and well-tolerated
The trial supports the potential for another chemotherapy backbone option that may be paired with encorafenib plus cetuximab in this patient population
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
Full approval will depend on verification of clinical benefit in a confirmatory trial
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
The Phase 3 HER2CLIMB-05 trial showed a 35.9% reduction in risk for patients treated with TUKYSA
Loperamide Hydrochloride is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhoea
Subscribe To Our Newsletter & Stay Updated
